Cross-metathesis of C-allyl iminosugars with alkenyl oxazolidines as a key step in the synthesis of C-iminoglycosyl α-amino acids. A route to iminosugar containing C-glycopeptides

Journal of Organic Chemistry

Volumn 70, Issue 14, 2005, Pages 5508-5518

  Dondoni, Alessandro ^a   Giovannini, Pier Paolo ^a   Perrone, Daniela ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CARBOXYLIC ACIDS; CATALYSIS; GLYCEROL; OLEFINS;

CROSS-METATHESIS; GLYCOPEPTIDE SYNTHESIS; IMINOSUGARS; OXAZOLIDINES;

SUGAR (SUCROSE);

ALKENE DERIVATIVE; ALPHA AMINO ACID; CARBOHYDRATE DERIVATIVE; GLUTAMIC ACID DERIVATIVE; GLYCOPEPTIDE; OXAZOLIDINE DERIVATIVE; VINYL DERIVATIVE;

AMINO ACID SYNTHESIS; ARTICLE; CATALYSIS; PEPTIDE SYNTHESIS; REACTION ANALYSIS; REDUCTION;

ALKENES; ALLYL COMPOUNDS; AMINO ACIDS; CATALYSIS; CYCLIZATION; GLYCOPEPTIDES; GLYCOSIDES; GLYCOSYLATION; IMINES; MOLECULAR STRUCTURE; OXAZOLES; OXIDATION-REDUCTION; STEREOISOMERISM;

EID: 22144461052     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo050494o     Document Type: Article

References (80)

1. 2H) through a carbon tether.
2. (a) Winchester, B.; Fleet, G. W. J. Glycobiology 1992, 2, 199.
3. (b) Stütz, A. E. Iminosugars as Glycosidase Inhibitors; Nojirimycin and Beyond; Wiley-VCH: Weinheim, Germany, 1999.
4. (a) Asano, N.; Nash, R. J.; Molyneux, R. J.; Fleet, G. W. J. Tetrahedron: Asymmetry 2000, 11, 1645.
5. (b) Watson, A. A.; Fleet, G. W. J.; Asano, N.; Molyneux, R. J.; Nash, R. J. Phytochemistry 2001, 56, 265.
6. For a basic treatise on this topic, see: Essentials of Glycobiology; Varki, A., Cummings, R., Esko, J., Freeze, H., Hart, G., Marth, J., Eds.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1999.
7. (a) Sears, P.; Wong, C.-H. Angew. Chem., Int. Ed. 1999, 38, 2300.
8. (b) Ossor, A.; Elbein, A. D. Glycoprotein Processing Inhibitors. In Carbohydrates in Chemistry and Biology; Ernst, B., Hart, G. W., Sinay, P., Eds.; Wiley-VCH: Weinheim, Germany, 2000; Part II, Vol. 3, p 513.
9. (c) Asano, N. Curr. Top. Med. Chem. 2003, 3, 471.
10. (d) Lillend, V. H.; Jensen, H. H.; Liang, X.; Bols, M. Chem. Rev. 2002, 102, 515.
11. (a) Compain, P.; Martin, O. R. Bioorg. Med. Chem. 2001, 9, 3077.
12. (b) Schuster, M.; Blechert, S. Bioorg. Med. Chem. Lett. 2001, 11, 1809.
13. (c) Bastida, A.; Fernandez-Mayoralas, A.; Arrayas, R. G.; Iradier, F.; Carretero, J. C.; Garcia-Junceda, E. Chem. Eur. J. 2001, 7, 2390.
14. (d) Compain, P.; Martin, O. R. Curr. Top. Med. Chem. 2003, 3, 541.
15. (e) Marotte, K.; Ayad, T.; Génisson, Y.; Besra, G. S.; Baltas, M.; Prandi, J. Eur. J. Org. Chem. 2003, 2557.
16. (a) Miles, R. W.; Tyler, P. C.; Furneaux, R. H.; Bagdassarian, C.; Schramm, V. L. Biochemistry 1998, 37, 8615.
17. (b) Evans, G. B.; Furneaux, R. H.; Hutchinson, T. L.; Kezar, H. S.; Morris, P. E., Jr.; Schramm, V. L.; Tyler, P. C. J. Org. Chem, 2001, 66, 5723.
18. (c) Fedorov, A.; Shi, W.; Kicska, G.; Fedorov, E.; Tyler, P. C.; Furneaux, R. H.; Hanson, J. C.; Gainsford, G. J.; Larese, J. Z.; Schramm, V. L.; Almo, S. C. Biochemistry 2001, 40, 853.
19. (d) Evans, G. B.; Furneaux, R. H.; Hausler, H.; Larsen, J. S.; Tyler, P. C. J. Org. Chem. 2004, 69, 2217.
20. Truscheit, E.; Frommer, W.; Junge, B.; Müller, L.; Schmidt, D. D.; Wingender, W. Angew. Chem., Int. Ed. Engl. 1981, 20, 744.
21. (b) Horii, S.; Fukase, H.; Matsuo, T.; Kameda, Y.; Asano, N.; Matsui, K. J. Med. Chem. 1986, 29, 1038.
22. (c) Horii, S.; Fukase, H.; Matsuo, T.; Kameda, Y.; Asano, N.; Matsui, K. Drugs Future 1986, 11, 1039.
23. (d) Elbein, A. D. Annu. Rev. Biochem. 1987, 56, 497.
24. (e) Anzeveno, P. B.; Creemer, L. J.; Daniel, J. K.; King, C.-H. R.; Liu, P. S. J. Org. Chem. 1989, 54, 2539.
25. (f) Andersen, B.; Rassov, A.; Westergaard, N.; Lundgren, K. Biochem. J. 1999, 342, 545.
26. Bernacki, R. J.; Niedbala, M. J.; Korytnyk, W. Cancer Metastasis Rev. 1985, 4, 81.
27. (b) Humphries, M. J.; Matsumoto, K.; White, S. L.; Olden, K. Cancer Res. 1986, 46, 5215.
28. (c) Spearman, M. A.; Jamieson, J. C.; Wright, J. A. Exp. Cell. Res. 1987, 168, 116.
29. (d) Tsukamoto, K.; Uno, A.; Shimada, S.; Imokaw, G. Clin. Res. 1989, 37A, 722.
30. (e) Goss, P. E.; Baptiste, J.; Fernandes, B.; Baker, M.; Dennis, J. W. Cancer Res. 1994, 54, 1450.
31. (f) Goss, P. E.; Baker, M. A.; Carver, J. P.; Dennis, J. W. Clin. Cancer. Res. 1995, 1, 935.
32. (g) Nishimura, Y.; Satoh, T.; Adachi, H.; Kondo, S.; Takeuchi, T.; Azetaka, M.; Fukuyasu, H.; Lizuka, Y. J. Med. Chem. 1997, 40, 2626.
33. (a) Häusler, H.; Kawakami, P.; Mlaker, E.; Severn, W. B.; Wrodnigg, T. M.; Stütz, A. E. J. Carbohydr. Chem. 2000, 19, 435.
34. (b) Durantel, D.; Branza-Nichita, N.; Carrouee-Durantel, S.; Butters, T. D.; Dwek, R. A.; Zitzmann, N. J. Virol. 2001, 75, 8987.
35. (a) Gruters, R. A.; Neefjes, J. J.; Tersmette, M.; de Goede, R. E. Y.; Tulp; A.; Huisman, H. G.; Miedema, F.; Ploegh, H. L. Nature 1987, 330, 74.
36. (b) Datema, R.; Olafsson, S.; Romero, P. A. Pharmacol. Ther. 1987, 33, 221.
37. (c) Tyms, A. S.; Berrie, E. M.; Ryder, T. A.; Nash, R. J.; Hegarty, M. P.; Taylor, D. L.; Mobberley, M. A.; Davis, J. M.; Bell, E. A.; Jeffries, D. J.; Taylor-Robinson, D.; Fellows, L. E. Lancet 1987, 2, 1025.
38. (d) Karpas, A.; Fleet, G. W. J.; Dwek, R. A.; Petursson, S.; Namgoong, S. K.; Ramsden, N. G.; Jacob, J. S.; Rademacher, T. W. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 9229.
39. (e) Fenouillet, E.; Papandreou, M. J.; Jones, I. M. Virology 1997, 231, 89.
40. (a) Davis, B. G.; Brandstetter, T. W.; Hackett, L.; Winchester, B. G.; Nash, R. J.; Watson, A. A.; Griffiths, R. C.; Smith, C.; Fleet, G. W. J. Tetrahedron 1999, 55, 4489
41. (b) Shilvock, J. P.; Wheatley, J. R.; Nash, R. J.; Watson, A. A.; Griffiths, R. C.; Butters, T. D.; Muller, M.; Watkin, D. J.; Winkler, D. A.; Fleet, G. W. J. J. Chem. Soc., Perkin Trans, 1 1999, 2735.
42. Fan, J. Q.; Ishii, S.; Asano, N.; Suzuki, Y. Nat. Med. 1999, 5, 112.
43. (a) Li, C. M.; Tyler, P. C.; Furneaux, R. H.; Kicska, G.; Xu, Y. M.; Grubmeyer, C.; Girvin, M. E.; Schramm, V. L. Nat. Struct. Biol. 1999, 6, 582.
44. (b) Miles, R. W.; Tyler, P. C.; Evans, G. B.; Furneaux, R. H.; Parkin, D. W.; Schramm, V. L. Biochemistry 1999, 38, 13147.
45. Martin, O. R. Toward Azaglycoside Mimics: Aza-C-glycosyl Compounds and Homoazaglycosides. In Carbohydrate Mimics, Concepts and Methods; Chapleur, Y., Ed.; Wiley-VCH: Weinheim, Germany, 1998; p 259.
46. Robina, I.; Vogel, P. Synlett 2005, 5, 675.
47. (a) Johnson, C. R.; Miller, M. W.; Golebiowski, A.; Sundram, H.; Ksebati, M. B. Tetrahedron Lett. 1994, 35, 8991.
48. (b) Johns, B. A.; Pan, Y. T.; Elbein, A. D.; Johnson, C. R. J. Am. Chem. Soc. 1997, 119, 4856.
49. Legler, G. The Catalytic Efficiency of Glycoside Hydrolases and Models of the Transition State Based on Substrate Related Inhibitors. In Carbohydrate Mimics, Concepts and Methods; Chapleur, Y., Ed.; Wiley-VCH: Weinheim, Germany, 1998; p 463.
50. It is worth recalling that also Wong and co-workers were at the forefront of azasugar-containing disaccharide and nucleoside synthesis "...in an effort to develop specific glycosidase inhibitors, as many glycosidases which recognize the same glycon moiety may differ only with the substrate aglycon portion and the type of glycosidic linkage". However, the compounds prepared by the Wong group featured an aminomethyl bridge between the two molecular residues. See: Wong, C.-H.; Provencher, L. Porco, J. A., Jr.; Jung, S.-H.; Wang, Y.-F.; Chen, L.; Wang, R.; Steensma, D. H. J. Org. Chem. 1995, 60, 1492.
51. (a) Dondoni, A.; Giovannini, P. P.; Perrone, D. J. Org. Chem. 2002, 67, 7203.
52. (b) Dondoni, A.; Perrone, D. Tetrahedron 2003, 59, 4261.
53. Shibano, M.; Tsukamoto, D.; Kusano, G. Heterocycles 2002, 57, 1539.
54. Trost, B. M.; Horne, D. B.; Woltering, M. J. Angew. Chem., Int. Ed. 2003, 42, 5987.
55. Dondoni, A.; Marra, A. Chem. Rev. 2000, 100, 4395.
56. Fuchss, T.; Schmidt, R. R. Synthesis 2000, 259.
57. Fuchss, T.; Schmidt, R. R. Synthesis 1998, 753.
58. For recent reviews, see: (a) Trnka, T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34, 18.
59. (b) Louie, J.; Grubbs, R. H. Angew. Chem., Int. Ed. 2001, 40, 247.
60. (c) Connon, S. J.; Blechert, S. Angew. Chem., Int. Ed. Engl. 2003, 42, 1900.
61. (d) Grubbs, R. H. Tetrahedron 2004, 60, 7117.
62. Dondoni, A.; Giovannini, P. P.; Marra, A. J. Chem. Soc., Perkin Trans. 1 2001, 2380
63. (a) Hu, Y.-J.; Roy, R. Tetrahedron Lett. 1999, 40, 3305
64. (b) Godin, G.; Compain, P.; Martin, O. R. Org. Lett. 2003, 5, 3269.
65. (c) Vernall, A. J.; Abell, A. D. Aldrichim. Acta 2003, 36, 93.
66. (a) Dondoni, A.; Marra, A.; Massi, A. Chem. Commun. 1998, 1741.
67. (b) Dondoni, A.; Massi, A.; Marra, A. Tetrahedron Lett. 1998, 39, 6601.
68. (c) Dondoni, A.; Marra, A.; Massi, A. J. Org. Chem. 1999, 64, 933.
69. (d) Dondoni, A.; Giovannini, P. P.; Marra, A. J. Chem. Soc., Perkin Trans. 1 2001, 2380.
70. (e) Dondoni, A.; Mariotti, G.; Marra, A.; Massi, A. Synthesis 2001, 2129.
71. (f) Dondoni, A.; Mariotti, G.; Marra, A. J. Org. Chem. 2002, 67, 4475.
72. (f) Dondoni, A.; Catozzi, N., Marra, A. J. Org. Chem. 2004, 69, 5023.
73. McKillop, A.; Taylor, R. J. K.; Watson, R. J.; Lewis, N. Synthesis 1994, 31
74. (a) Dondoni, A.; Perrone, D. Synthesis 1997, 527.
75. (b) Dondoni, A., Perrone, D. Org. Synth. 1999, 77, 64.
76. Dondoni, A.; Massi, A.; Minghini, E.; Bertolasi, V. Tetrahedron 2004, 60, 2311.
77. Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 7, 953.
78. 1H NMR spectrum and optical rotation value were identical with those of the starting material.
79. Armarego, W. L. F.; Perrin, D. D. Purification of Laboratory Chemicals, 5th ed.; Butterworth-Heinemann; Oxford, 2003.
80. Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923.